** Shares of Alcidion Group Ltd ALC.AX rise as much as 20.8% to A$0.145, their highest level since February 24, 2023
** The healthcare technology firm generates FY25 new total contract value $(TCV)$ sales of A$73.8 million ($48.82 million), up 10.9% from a year earlier
** Reconfirms outlook of FY25 EBITDA exceeding A$4.5 mln
** Co will release FY25 earnings results and FY26 guidance on August 28
** Around 5.7 mln shares change hands, 4.4x the 30-day avg
** Stock last up 4.2%, bringing YTD gains to 108.3%
($1 = 1.5117 Australian dollars)
(Reporting by Shruti Agarwal in Bengaluru)
((Shruti.Agarwal@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.